Treatment of obesity: Need to focus on high risk abdominally obese patients

British Medical Journal

Volumn 322, Issue 7288, 2001, Pages 716-720

  Despres J P ^a   Lemieux, I ^b   Prud'homme, D ^c  

^a LAVAL UNIVERSITY   (Canada)

^b Université Laval   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMEN; ADIPOSE TISSUE; ANTHROPOMETRY; BODY MASS; CARDIOVASCULAR RISK; DYSLIPIDEMIA; HIGH RISK PATIENT; HUMAN; MEASUREMENT; OBESITY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR;

EID: 0035941940     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.322.7288.716     Document Type: Review

References (26)

1. Indices of relative weight and obesity
2. La différenciation sexuelle, facteur déterminant des formes de l'obésité
3. Health risks of obesity
4. Contributions of regional adipose tissue depots to plasma lipoprotein concentrations in overweight men and women: Possible protective effects of thigh fat
5. Associations between regional body fat distribution, fasting plasma free fatty acid levels and glucose tolerance in premenopausal women
6. Waist circumference and abdominal sagittal diameter: Best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women
7. Anthropometric correlates to changes in visceral adipose tissue over 7 years in women
8. Diabetes and atherosclerosis: An epidemiologic view
9. Association of elevated fasting C-peptide level and increased intra-abdominal fat distribution with development of NIDDM in Japanese-American men
10. Visceral obesity in men. Associations with glucose tolerance, plasma insulin, and lipoprotein levels
11. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease
12. Hypertriglyceridemic waist. A marker of the atherogenic metabolic triad (hyperinsulinemia, hyperapolipoprotein B, small, dense LDL) in men?
13. Epidemiology of coronary heart disease: The Framingham study
14. The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men
15. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease
16. A single threshold value of waist girth identifies normal-weight and overweight subjects with excess visceral adipose tissue
17. Seven-year changes in body fat and visceral adipose tissue in women. Association with indexes of plasma glucose-insulin homeostasis
18. Change in LDL particle size is associated with change in plasma triglyceride concentration
19. Waist circumference as a measure for indicating need for weight management
20. Impairment of health and quality of life in people with large waist circumference
21. Waist circumference action levels in the identification of cardiovascular risk factors: Prevalence study in a random sample
22. Pharmacotherapy for obesity
23. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients